Astrazeneca Pharma I - Quaterly Results

26 May 2022 Evaluate
The company witnessed a 10.32% growth in the revenue at Rs. 2319.63 millions for the quarter ended March 2022 as compared to Rs. 2102.57 millions during the year-ago period.Profit for the quarter ended March 2022 grew by 2.59% to Rs. 279.84 millions from Rs. 272.78 millions.The Operating Profit of the company witnessed a decrease to 416.45 millions from 429.62 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 2319.63 2102.57 10.32 8056.00 8135.63 -0.98 8056.00 8135.63 -0.98
Other Income 36.84 25.53 44.30 147.58 128.41 14.93 147.58 128.41 14.93
PBIDT 416.45 429.62 -3.07 1009.33 1483.12 -31.95 1009.33 1483.12 -31.95
Interest 2.07 2.82 -26.60 9.47 10.93 -13.36 9.47 10.93 -13.36
PBDT 414.38 426.80 -2.91 999.86 1472.19 -32.08 999.86 1472.19 -32.08
Depreciation 44.07 58.42 -24.56 169.49 201.26 -15.79 169.49 201.26 -15.79
PBT 370.31 368.38 0.52 830.37 1270.93 -34.66 830.37 1270.93 -34.66
TAX 90.47 95.60 -5.37 214.43 337.90 -36.54 214.43 337.90 -36.54
Deferred Tax -1.67 10.11 -116.52 -11.86 -10.38 14.26 -11.86 -10.38 14.26
PAT 279.84 272.78 2.59 615.94 933.03 -33.98 615.94 933.03 -33.98
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 17.95 20.43 -12.14 12.53 18.23 -31.27 12.53 18.23 -31.27

Astrazeneca Pharma I Share Price

8251.95 -35.35 (-0.43%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×